Literature DB >> 16818172

The genetic and molecular pathogenesis of NF1 and NF2.

Kaleb H Yohay1.   

Abstract

Neurofibromatosis types 1 and 2 (NF1 and NF2) are autosomal dominant phakomatoses. The NF1 and NF2 genes encode for neurofibromin and merlin, respectively. These 2 functionally unrelated proteins both act as tumor suppressor genes, possibly through modulation of the RAS/RAC oncogenic pathways. Improved understanding of the mechanisms by which these tumor suppressors act may allow for medical therapies for neurofibromatosis and may offer insights for cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818172     DOI: 10.1016/j.spen.2006.01.007

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  17 in total

1.  Refractive errors in neurofibromatosis type 1 and type 2.

Authors:  Arsen Akinci; Golge Acaroglu; Alev Guven; Aydan Degerliyurt
Journal:  Br J Ophthalmol       Date:  2007-01-03       Impact factor: 4.638

2.  Clinical and molecular characteristics of thirty NF1 variants in Chinese patients with neurofibromatosis type 1.

Authors:  Wen Wang; Weibing Qin; Hongsong Ge; Xiangsheng Kong; Chao Xie; Yunge Tang; Ming Li
Journal:  Mol Biol Rep       Date:  2019-06-14       Impact factor: 2.316

3.  Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene.

Authors:  Bernadett Balla; Kristóf Árvai; Péter Horváth; Bálint Tobiás; István Takács; Zsolt Nagy; Magdolna Dank; György Fekete; János P Kósa; Péter Lakatos
Journal:  J Mol Neurosci       Date:  2014-03-28       Impact factor: 3.444

Review 4.  Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.

Authors:  Ivan Stamenkovic; Qin Yu
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

Review 5.  Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.

Authors:  L Q Le; L F Parada
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

6.  Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.

Authors:  Georgette N Jones; Chhavy Tep; William H Towns; Georgeta Mihai; Ian D Tonks; Graham F Kay; Petra M Schmalbrock; Anat O Stemmer-Rachamimov; Sung Ok Yoon; Lawrence S Kirschner
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

7.  Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2.

Authors:  Chunling Yi; Erik W Wilker; Michael B Yaffe; Anat Stemmer-Rachamimov; Joseph L Kissil
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

8.  Non-excision treatment of multiple cutaneous neurofibromas by laser photocoagulation.

Authors:  Tarek F Elwakil; Nevien A Samy; Mahmoud S Elbasiouny
Journal:  Lasers Med Sci       Date:  2007-08-15       Impact factor: 3.161

9.  GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma.

Authors:  Ty W Abel; Cara Clark; Brian Bierie; Anna Chytil; Mary Aakre; Agnieszka Gorska; Harold L Moses
Journal:  Mol Cancer Res       Date:  2009-05-12       Impact factor: 5.852

10.  Radiofrequency ablation and excision of multiple cutaneous lesions in neurofibromatosis type 1.

Authors:  Seong-Hun Kim; Si-Gyun Roh; Nae-Ho Lee; Kyung-Moo Yang
Journal:  Arch Plast Surg       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.